Hospital Clinico San Carlos — Clinical Trial Site

548 Registered trials

215 Currently recruiting

Organisation

Hospital Clinico San Carlos

Location

Madrid, Spain

Identifier

ORG-100023073

Address

Planta Baja Sur 1, Pasillointerior, 28040, Spain

Departments

-
#034018 Oncología
#1901:Cardiología
#2100:Oncología
#2107: Oftalmología
#2304:servicio de neurología
#2401: Neurología
#2450: Oncología Médica
#3184: Nefrología
#3458: Medicina Interna
#3811: UCI/medicina intensiva
#4006: Nefrología
#4502: Cardiología
#5401 :neurologia
#762; Oncología Médica
03405: Oncología Médica
03406:Oncología Médica
1207:Oncología Médica
1301: Neurology
1505: Oncology
2107:Oftalmología
2142:Nefrología
2455:Oncologia
2604:Oncology
3006: Oncología
3100:Servicio alergología
3103: neurologia
3125: Cardiología
34003: Oncología Médica
3512: Cardiologia
40161: Neurologia
476: Oftalmología
7001: Oncología Médica
7003: Oncología Médica
7005:Oncología Médica
7114:Oncología
7211: Neurology
Allergology
Allergy
Anestesia y Reanimación
Anesthesiology
Área de medicina interna, despacho médico
Cardiac surgery
Cardiologia
Cardiology
Cardiology Service
Cardiovascular Risk
Centro Sanitario Sandoval, Servicio de Medicina Interna
Clinical Immunology
Clinical Pharmacology
Comité ético de investigación clínica
Critical Care
Critical Care Department
Critical Care Unit
Departamento de Cirugía
Departamento de Neurología
Dept of Medical Oncology
Dermatology
Dermatology department
Digestive department
Endocrinology
Endrocrinology
Enfermedades Infecciosas
ESP003: Oncología Médica
ESP4: Oftalmologia
Farmacologia Clinica
Gastroenterology
General Surgery
Gynecologic Tumors and Sarcoma Unit
Gynecology
Head of HIV/Infectious Diseases Section (Internal Medicine)
Hematología
Hematology
Hematology service
Immunology
Infecciosas
Infectious
Infectious department
Infectious Diseases
Infectious diseases service
Infectious Diseases/ Internal Medicine
Intensive Care
Intensive Care Department
Internal Medicine
Internal Medicine Infectious Diseases
Internal Medicine-Infectious Diseases
Interventional Cardiology
Maxilofacial
Medica Oncology
Medical Doctor
Medical Oncology
Medical Oncology Department
Medical Oncology Service
Medicina Interna
Medicine
N/A
NA
Nefrology
Neonatology Department
Nephrology
Nephrology Department
NEUMOLOGÍA
Neurología
Neurology
Neurology Department
Neurology Service
Neurology/Institute of Neuroscience
Neurophysiology
Oftalmologia
Oncología
Oncología Médica
Oncology
Oncology Department
Oncology seervice
Oncology Service
Ophtalmology
Ophthalmology
Ophthalmology service
Paredes
Pediatria
Pediatric Department
Pediatric Surgery
Pediatrics
Pediatrics Department. Neuropedriatric Unit
Pneumology
Pneumology Department
Prevención y Salud Laboral
Prevention and Occupational Health
Psiquiatría
Psychiatry
Pulmonología
Pulmonology
Radiation Oncology
Reumatología
Rheumatology
Serv. Dermatovenereologia
Servicio de Cardiología
Servicio de Dermatologia
Servicio de Endocrinología, Metabolismo y Nutrición
Servicio de Farmacología Clínica
Servicio de Infecciosas
Servicio de Medicina Interna
Servicio de Microbiología
Servicio de Nefrología
Servicio de Neumologia
Servicio de Neurología
Servicio de Oncología
Servicio de Oncología Médica
Servicio de Oncología Médica Planta 0 Sur
Servicio de Prevención y Riesgos Laborales
SERVICIO DE PSIQUIATRIA
Servicio Endorinologia
Servicio Oncologia Medica
Servicio Pediatria-Neuropediatria
Sleep Unit
Unidad de Hipertension y Factores de Riesgo
Unidad de Retina
Urology

Clinical trials at this site (548)

Search interface

Clinical trial to compare the efficacy of two treatment sequencing schemes with chemotherapy (the regime called FOLFOX and FOLFIRI) in combi… Ended

2024-510967-41-00 Metastatic colorectal cancer 5 2018-09-21
Randomized trial evaluating the addition of nivolumab to cisplatin-radiotherapy combination for treatment of cancers of the head and neck Ended

2024-513206-65-00 resected squamous cell carcinoma of head and neck 5 2018-08-10
Study to evaluate the efficacy and safety of Durvalumab(MEDI4736) in combination with intravesical BCG for the treatment of patients diagnos… Ended

2023-505341-23-00 Non-muscle invasive bladder cancer 5 2018-07-27
A study of TG4001 and avelumab cancer immunotherapies in advanced HPV-induced malignancies Ended

2024-515119-23-00 Phase Ib and Phase II part 1: HPV-16 positive recurrent 9 2017-08-29
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended

2023-509671-17-00 Breast Cancer 5 2017-07-12
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors Ended

2023-506390-35-00 Patients with Advanced Solid Tumors 1 2017-04-19
Phase I-II trial of sunitinib and/or nivolumab plus chemotherapy in advanced soft tissue and bone sarcomas Ended

2024-514776-40-00 Advanced soft tissue and bone sarcomas 9 2017-03-23
Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Expos… Ended

2022-501763-40-00 Pre-Exposure Prophylaxis of HIV-1 Infection 5 2016-12-13
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lun… Ended

2023-505981-26-00 Non−Small Cell Lung Cancer 5 2015-11-20
A trial to learn how well osimertinib (AZD9291) works to prevent cancer from coming back after surgery and how safe it is compared to the pl… Ended

2023-506524-82-00 Stage IB-IIIA non-small cell lung carcinoma, with a cen 5 2015-10-21
Study to evaluate the effectiveness of a combination of 3 treatments, followed by transplantation of their own blood cell progenitor cells f… Ended

2024-516908-42-00 Smoldering multiple myeloma with high risk of progressi 4 2015-06-15
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-6404… Halted

2023-505096-68-00 Preclinical Alzheimer’s Disease 4 2025-01-14
Phase 2 Study of CAL02 plus Standard of Care in Severe Community-Acquired Bacterial Pneumonia (SCABP) Halted

2022-502049-91-00 SEVERE COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (SCABP) 4 2023-09-26
A study to investigate pharmacokinetics, safety, and tolerability of Cefepime-Enmetazobactam administered by intra-venous infusion over 2 ho… Halted

2024-518003-22-00 Complicated urinary tract infections including acute py 4 2023-01-20
OPEN-LABEL PALATABILITY STUDY OF A NOVEL ORODISPERSIBLE PARACETAMOL/IBUPROFEN FORMULATION AFTER A SINGLE ORAL ADMINISTRATION IN HEALTHY SUBJ… Ended

2025-524274-41-00 Healthy volunteers 3 2026-01-26
RANDOMIZED, CROSSOVER, TWO-PERIOD, COMPARATIVE BIOAVAILABILITY STUDY OF TWO IBUPROFEN FORMULATIONS, AFTER A SINGLE ORAL DOSE OF 400 MG IN SO… Ended

2025-520852-27-00 Healthy volunteers 3 2025-09-18
Randomized, open-label, three-period crossover study on the palatability of oral dispersible formulations of Zonisamide in healthy volunteer… Ended

2025-522297-36-00 Healthy volunteers 3 2025-09-03
Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated Ended

2024-512505-66-00 HIV-1 Infection 10 2025-03-03
Randomized, crossover, comparative bioavailability study of two Paracetamol-Ibuprofen 25-20 mg/ml oral suspension, administered in single do… Ended

2024-519661-22-00 Healthy volunteers 3 2025-03-03
N/A Ended

2024-513121-22-00 Recurrent or Metastatic Head and Neck Squamous Cell Car 4 2025-02-04
Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated… Ended

2024-511030-12-00 Non-small Cell Lung Cancer (NSCLC) 3 2025-02-03
A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1) Ended

2024-514559-13-00 Focal Epilepsy 10 2024-11-26
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as … Ended

2024-511557-21-00 Major Depressive Disorder (MDD) with Moderate-to-severe 5 2024-11-14